Molecular Analysis of Cell Survival and Death Pathways in the Proteasome Inhibitor Bortezomib-Resistant PC3 Prostate Cancer Cell Line

0
13
Researchers verified the resistance levels of parental and resistant PC3 prostate cancer cells to bortezomib using WST-1 test.
[Medical Oncology]
Abstract